HCPCS Code C9082

Injection, dostarlimab-gxly, 100 mg
Code effective Jan 01, 2022

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9082 is a valid 2026 HCPCS code meaning Injection, dostarlimab-gxly, 100 mg or (Inj dostarlimab-gxly, 100 mg) for short. HCPCS C9082 has been effective since 01/01/2022 and applies to Other medical items or services.

HCPCS Code Details - C9082

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9082
Description

Long description:
Injection, dostarlimab-gxly, 100 mg

Short description:
Inj dostarlimab-gxly, 100 mg

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Jan 01, 2022
Date added Added Oct 01, 2021
Termination date Dec 31, 2021

See also

  • HCPCS C9081 · Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • HCPCS C9083 · Injection, amivantamab-vmjw, 10 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.